JP2020532548A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020532548A5 JP2020532548A5 JP2020512637A JP2020512637A JP2020532548A5 JP 2020532548 A5 JP2020532548 A5 JP 2020532548A5 JP 2020512637 A JP2020512637 A JP 2020512637A JP 2020512637 A JP2020512637 A JP 2020512637A JP 2020532548 A5 JP2020532548 A5 JP 2020532548A5
- Authority
- JP
- Japan
- Prior art keywords
- release
- composition
- release component
- tablets
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 32
- 150000001875 compounds Chemical class 0.000 claims 13
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 12
- 239000003826 tablet Substances 0.000 claims 11
- 239000008185 minitablet Substances 0.000 claims 10
- 238000013268 sustained release Methods 0.000 claims 9
- 239000012730 sustained-release form Substances 0.000 claims 9
- 239000008188 pellet Substances 0.000 claims 8
- DYZJXZOQQRXDLE-UHFFFAOYSA-O Suplatast tosilate Chemical compound CCOCC(O)COC1=CC=C(NC(=O)CC[S+](C)C)C=C1 DYZJXZOQQRXDLE-UHFFFAOYSA-O 0.000 claims 7
- 239000008187 granular material Substances 0.000 claims 7
- 229950001956 suplatast Drugs 0.000 claims 7
- 229950004288 tosilate Drugs 0.000 claims 7
- 239000011248 coating agent Substances 0.000 claims 5
- 238000000576 coating method Methods 0.000 claims 5
- 150000002148 esters Chemical class 0.000 claims 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000002775 capsule Substances 0.000 claims 3
- 239000002552 dosage form Substances 0.000 claims 3
- -1 spheres Substances 0.000 claims 3
- 239000007939 sustained release tablet Substances 0.000 claims 3
- RYVJQEZJUFRANT-UHFFFAOYSA-N [3-[4-(3-ethoxy-2-hydroxypropoxy)anilino]-3-oxopropyl]-dimethylsulfanium;4-methylbenzenesulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.CCOCC(O)COC1=CC=C(NC(=O)CC[S+](C)C)C=C1 RYVJQEZJUFRANT-UHFFFAOYSA-N 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000008186 active pharmaceutical agent Substances 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 239000007931 coated granule Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000007888 film coating Substances 0.000 claims 1
- 238000009501 film coating Methods 0.000 claims 1
- 239000006186 oral dosage form Substances 0.000 claims 1
- 239000008184 oral solid dosage form Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 239000007909 solid dosage form Substances 0.000 claims 1
- 229950011082 suplatast tosilate Drugs 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17188229 | 2017-08-29 | ||
| EP17188229.3 | 2017-08-29 | ||
| PCT/EP2018/073123 WO2019042995A1 (en) | 2017-08-29 | 2018-08-28 | COMPOSITION COMPRISING SUPLATAST TOSILATE |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020532548A JP2020532548A (ja) | 2020-11-12 |
| JP2020532548A5 true JP2020532548A5 (enExample) | 2021-09-30 |
| JP7330948B2 JP7330948B2 (ja) | 2023-08-22 |
Family
ID=59745229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512637A Active JP7330948B2 (ja) | 2017-08-29 | 2018-08-28 | トシル酸スプラタストを含む組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11819482B2 (enExample) |
| EP (1) | EP3675831A1 (enExample) |
| JP (1) | JP7330948B2 (enExample) |
| KR (1) | KR20200045496A (enExample) |
| CN (1) | CN111032021A (enExample) |
| AU (1) | AU2018322756B2 (enExample) |
| CA (1) | CA3073866A1 (enExample) |
| WO (1) | WO2019042995A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12303604B1 (en) | 2024-10-16 | 2025-05-20 | Currax Pharmaceuticals Llc | Pharmaceutical formulations comprising naltrexone and/or bupropion |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4556737A (en) | 1983-03-11 | 1985-12-03 | Taiho Pharmaceutical Company Limited | Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same |
| JPS6168455A (ja) | 1984-09-12 | 1986-04-08 | Taiho Yakuhin Kogyo Kk | アミド化合物 |
| JPH0370698A (ja) | 1989-08-11 | 1991-03-26 | Naomasa Nomura | 頭部回転式高性能飛行機 |
| WO1995003052A1 (en) * | 1993-07-22 | 1995-02-02 | Warner-Lambert Company | Controlled release tacrine drug delivery systems and methods for preparing same |
| AU5200098A (en) | 1996-11-01 | 1998-05-29 | Ilex Oncology, Inc. | Sustained release formulation containing dfmo |
| JP2002179554A (ja) | 1997-09-05 | 2002-06-26 | Takeda Chem Ind Ltd | 医 薬 |
| FR2772615B1 (fr) | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
| JP2002523358A (ja) | 1998-08-25 | 2002-07-30 | プラット，クリス | ナプロキセンおよびプソイドエフェドリンを含む徐法性錠剤 |
| US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
| US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| DK1295870T3 (da) * | 2001-04-16 | 2008-01-28 | Taiho Pharmaceutical Co Ltd | Suplatasttosilatkrystaller |
| WO2002087549A1 (fr) | 2001-04-25 | 2002-11-07 | Taisho Pharmaceutical Co., Ltd. | Comprimes a liberation prolongee du type a unites multiples |
| JP4974419B2 (ja) * | 2001-06-12 | 2012-07-11 | 東和薬品株式会社 | 薬物含有徐放性顆粒およびそれを含む錠剤 |
| AU2003202550A1 (en) | 2002-01-09 | 2003-07-24 | Ucb, S.A. | Pharmaceutical formulations with modified release |
| US20100092562A1 (en) | 2002-11-26 | 2010-04-15 | Hollenbeck R Gary | Sustained-release drug delivery compositions and methods |
| EP1591109B1 (en) | 2004-04-30 | 2008-07-02 | TopoTarget Germany AG | Formulation comprising histone deacetylase inhibitor exhibiting biphasic release |
| JP4498101B2 (ja) | 2004-11-04 | 2010-07-07 | 大鵬薬品工業株式会社 | 頭痛の予防及び／または治療剤 |
| AU2006263120B2 (en) * | 2005-06-27 | 2010-02-25 | Juntendo Educational Foundation | Herpesvirus-derived therapeutic agent for pain |
| JP2006335771A (ja) | 2006-09-22 | 2006-12-14 | Takeda Chem Ind Ltd | 徐放性製剤およびその製造方法 |
| EP1973528B1 (en) | 2006-11-17 | 2012-11-07 | Supernus Pharmaceuticals, Inc. | Sustained-release formulations of topiramate |
| US20100056552A1 (en) * | 2007-03-30 | 2010-03-04 | Johan Raud | Combination for use in the treatment of inflammatory disorders |
| CN101028254B (zh) * | 2007-04-05 | 2010-05-19 | 合肥合源医药科技股份有限公司 | 一种多索茶碱缓释制剂及其制备方法 |
| CN101590022A (zh) * | 2008-05-29 | 2009-12-02 | 焦作平光制药有限责任公司 | 甘氨酸茶碱钠缓释片及其制备方法 |
| JP2011246454A (ja) * | 2010-04-27 | 2011-12-08 | Daiichi Sankyo Healthcare Co Ltd | 安全な免疫抑制剤または免疫異常抑制剤組成物 |
| CN102210688B (zh) * | 2011-05-24 | 2013-04-03 | 赛乐医药科技(上海)有限公司 | 复方甲氧那明的速释-缓释制剂 |
| EP3302442B1 (en) * | 2015-06-03 | 2024-10-16 | Triastek, Inc. | Dosage forms and use thereof |
| WO2017032384A1 (en) | 2015-08-25 | 2017-03-02 | Conrig Pharma Aps | Compound and use in the treatment of cough |
| ES2862799T3 (es) | 2015-12-23 | 2021-10-07 | Conrig Pharma Aps | Tosilato de suplatast para tratar la tos asociada con neumopatía intersticial |
-
2018
- 2018-08-28 US US16/641,524 patent/US11819482B2/en active Active
- 2018-08-28 AU AU2018322756A patent/AU2018322756B2/en not_active Expired - Fee Related
- 2018-08-28 WO PCT/EP2018/073123 patent/WO2019042995A1/en not_active Ceased
- 2018-08-28 CN CN201880056343.6A patent/CN111032021A/zh active Pending
- 2018-08-28 EP EP18759323.1A patent/EP3675831A1/en not_active Withdrawn
- 2018-08-28 KR KR1020207006620A patent/KR20200045496A/ko not_active Ceased
- 2018-08-28 CA CA3073866A patent/CA3073866A1/en active Pending
- 2018-08-28 JP JP2020512637A patent/JP7330948B2/ja active Active